Mandate

Vinge represents ADB BVBA in connection with the acquisition of Safegate

February 26, 2016

Vinge, together with Willkie Farr & Gallagher, represents ADB BVBA, a portfolio company to the French private equity fund PAI Partners, in its acquisition of Safegate from Fairford. Together they will form the new ADB Safegate group.

Safegate is a leading airfield solutions business providing aircraft docking guidance systems, gate management systems, airfield lighting solutions and air traffic control systems to more than 1,300 airports in 130 countries. Safegate is headquartered in Malmö, Sweden, has more than 300 employees worldwide and generated revenue of SEK 1.3 billion in 2015. The ADB Group comprises ADB Airfield Solutions, LUCEBIT and ERNI AGL, three world-leading airfield technology companies specializing in end-to-end, integrated and sustainable solutions for visual guidance. The ADB Group has a worldwide presence and experience spanning 69 years in airfield lighting. More than 2000 airports in 175 countries have chosen ADB as their preferred partner for airside operations.

Vinge’s team primarily consisted of Jonas Bergström, Maria Dahlin, Ulrich Ziche, Samra Baytar, Manne Bergström, Linn Adelwald, Adam Sandberg, Maria Schultzberg, Jasmin Draszka-Ali, Carl Sander, Isabell Nielsen and Lova Unge.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025